BioSpace News Archive

REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a virtual investor day on July 11, 2023.

Aldeyra Therapeutics, Inc. today announced positive top-line results from the Phase 2 clinical trial of orally administered ADX‑629, an investigational new drug, in patients with chronic cough.

Alpha Healthcare Acquisition Corp. III announced the execution of a non-binding letter of intent to acquire a commercial stage regenerative medicine company conditioned upon the closing of ALPA’s initial business combination with Carmell Therapeutics Corporation, a Phase 2 stage regenerative medicine platform company developing allogeneic plasma-based biomaterials for active soft tissue repair, aesthetics and orthopedic indications.

Arch Biopartners Inc. announced today that it received a “Study May Proceed” letter from the U.S. Food and Drug Administration (FDA) for a Phase II human trial for LSALT peptide targeting cardiac surgery-associated acute kidney injury (CS-AKI).

KORU Medical Systems, Inc. today announced the appointment of Andrew D. C. LaFrence as its Chief Financial Officer, effective July 10, 2023.

Immutep Limited today announced the grant of a new patent (number 11,684,654) entitled “Combined Preparations for the Treatment of Cancer or Infection” by the United States Patent Office.

Tasso, Inc., the leading provider of patient-centric clinical-grade blood collection solutions, and United BioSource LLC (UBC) today announced a partnership to provide more efficient, streamlined, and convenient sample collection and analysis options for post-approval research to improve study design and enable a better patient experience.

DNAnexus Inc. today announced its platform is being used by researchers to access and analyze data from the Mexico City Prospective Study, the largest population health research study of its kind in Mexico.

Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Metrios™ 6 Scanning Transmission Electron Microscope ((S)TEM) — a new-generation, fully automated (S)TEM metrology solution designed to help enhance productivity and deliver data quality assurance for high-volume semiconductor manufacturing.

Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced the successful close of an $82.5 million Series D financing.